BRIAN LENG: Open Payments
NPI 1710673108 · CANYON COUNTRY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 73 payments from 18 companies in 2025. Trend: 2023 $124 · 2024 $1,144 · 2025 $2,239
Food & beverage: $2,035Education: $195Travel & lodging: $9
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $509 |
| E.R. Squibb & Sons, L.L.C. | 10 | $283 |
| Amgen Inc. | 9 | $246 |
| ABBVIE INC. | 5 | $199 |
| Arcutis Biotherapeutics, Inc. | 6 | $185 |
| Janssen Biotech, Inc. | 5 | $181 |
| Galderma Laboratories, L.P. | 7 | $152 |
| GENZYME CORPORATION | 3 | $133 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $121 |
| Incyte Corporation | 2 | $43 |
Products named: EBGLYSS, Sotyktu, Otezla, Zoryve, TREMFYA, DUPIXENT, NEMLUVIO, TALTZ.
Industry payments across CA — which companies pay providers there.
